Long-term remission in a patient with carcinoma of unknown primary site

Chemotherapy

Volumn 52, Issue 1, 2005, Pages 12-15

  Jentsch Ullrich, K ^a,b   Kalinski, T ^a   Roessner, A ^a   Franke, A ^a   Mohren, M ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

Cancer, primary; Long term remission; Papillary carcinoma; Unknown cancer

Indexed keywords

DOXORUBICIN; FLUOROURACIL;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER REGRESSION; CASE REPORT; DISEASE COURSE; EMPIRICISM; HUMAN; LYMPH NODE METASTASIS; MALE; PAPILLARY CARCINOMA; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; REMISSION INDUCTION; TEGAFUR; TIME FACTORS; TOMOGRAPHY SCANNERS, X-RAY COMPUTED;

EID: 29344453362     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090235     Document Type: Article

References (11)

1. Hess KR, Abbruzzese MC, Lenzi R, Raber MN, Abbruzzese JL: Classification and regression tree analysis of 1000 consecutive patients with unknown primary carcinoma. Clin Cancer Res 1999;5:3403-3410.
2. Pavlidis N: Cancer of unknown primary: biological and clinical characteristics. Ann Oncol 2003;14:iii12-iii18.
3. Pavlidis N, Briasoulis E, Hainsworth J, Greco FA: Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 2003;39:1990-2005.
4. Hainsworth JD, Greco FA: Management of patients with cancer of unknown primary site. Oncology (Huntingt) 2000;14:563-579.
5. Briasoulis E, Kalofonos H, Bafaloukos D, et al: Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II study. The Hellenic Cooperative Oncology Group Study. J Clin Oncol 2000;18:3101-3107.
6. Greco FA, Gray J, Burris HA, et al: Taxane-based chemotherapy for patients with carcinoma of unknown primary site. Cancer J 2001;7:203-212.
7. Piga A, Nortilli R, Cetto GL, Cardarelli N, Fedeli SL, Fiorentini G, D'Aprile M, et al: Carboplatin, doxorubicin and etoposide in the treatment of tumours of unknown primary site. Br J Cancer 2004;90:1898-1904.
8. Jadega J, Legha S, Burgess M, et al: Combination chemotherapy with 5-fluorouracil, Adriamycin, cyclophosphamide, and cis-platinum in the treatment of adenocarcinoma of unknown primary and undifferentiated carcinomas (abstract). Proc Am Soc Clin Oncol 1983;2:926.
9. van der Gast AVD, Verweij J, Planting ASTH, et al: 5-Fluorouracil, doxorubicin, and mitomycin C (FAM) combination chemotherapy for metastatic adenocarcinoma of unknown primary. Eur J Cancer Clin Oncol 1988;24:765-768.
10. Goldberg RM, Smith FP, Ueno W, et al: 5-Fluorouracil, Adriamycin, mitomycin in the treatment of adenocarcinoma of unknown primary. J Clin Oncol 1986;4:395-399.
11. Chandrasekaran S, Baba AA, Othman N, Jayakumar CR: Undifferentiated carcinoma of the sinuses and cranial basis successfully treated with radiochemotherapy. A case report. Chemotherapy 1994;40:357-361.